Rohto Pharmaceutical Co. financial statements, including revenue, expenses, profit, and loss

The total revenue of RPHCF for the last quarter is 460.36 M USD, and it's 11.37% lower compared to the previous quarter. The net income of Q4 23 is 31.57 M USD.